Body changes after starting GLP-1 medications for weight or diabetes
Part of Hormones & metabolism clinical trials.
This study looks at how your body composition (muscle and fat) changes after you start a GLP-1 medication for obesity or type 2 diabetes. You will be followed for a year with body scans to see the effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have a diagnosis of obesity and/or type 2 diabetes
- Be about to start, or currently in the dose-adjustment phase of, a GLP-1 medication (like semaglutide, liraglutide, or tirzepatide) as part of your regular care
- Be willing to come back for check-ups at 6 months and 12 months
- Not have certain conditions like type 1 diabetes, active cancer, severe heart failure, or kidney failure on dialysis
- Not be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how starting a GLP-1 medication (like Wegovy or Ozempic) changes your food choices and eating habits. It may help you understand if these medicines work for weight loss.
This study follows people who recently stopped taking a GLP-1 medication to see how their eating habits, daily routines, and weight change over time. It aims to learn how to better support people after they stop, helping them maintain a healthy weight.
This study compares how a GLP-1 medication (a drug that helps control blood sugar and weight) changes the way your body stores and uses fat. Researchers will use imaging scans to see these changes over time in people with metabolic syndrome—a cluster of health conditions including high blood pressure, high cholesterol, and excess weight.
This study tests whether a newer class of weight-loss medicines (GLP-1 and GIP/GLP-1 analogues) can help people with excess body weight eat healthier and improve their metabolism and behavior. It may be a good option if you are an adult with overweight or obesity and haven't used these medicines recently.
This study is looking at how certain diabetes medications affect the body's makeup (like muscle and fat) and how the body works, using special imaging scans. It may help doctors understand these treatments better and could guide future care.
This study looks at what happens when people taking a GLP-1 medication (like Ozempic) either stop or continue it after weight loss surgery. The goal is to learn whether staying on the medicine helps with long-term weight control.
Hear when a new Obesity (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.